Upgrades - DA Davidson upgraded Q2 Holdings (QTWO) to Buy from Neutral with an unchanged price target of $82, citing an attractive entry point due to the stock's pullback over the last 6-8 months [2] - Citi upgraded JetBlue (JBLU) to Neutral from Sell with a price target of $6, up from $4, noting "upside risks" and strategic optionality for the airline [3] - Morgan Stanley upgraded Affirm (AFRM) to Overweight from Equal Weight with a price target of $76, down from $83, highlighting a compelling risk/reward scenario following recent stock weakness [3] - Daiwa upgraded Visa (V) to Outperform from Neutral with an unchanged price target of $370, revising earnings forecasts upward in light of Q1 earnings [4] - Northland upgraded Palantir (PLTR) to Outperform from Market Perform with a price target of $190, up from $185, following the company's strong Q4 results [4] Downgrades - Piper Sandler downgraded Adobe (ADBE) to Neutral from Overweight with a price target of $330, down from $470, due to concerns over seat-compression and vibe coding narratives [5] - RBC Capital downgraded Elevance Health (ELV) to Sector Perform from Outperform with a price target of $358, down from $392, citing softer than expected 2026 guidance [5] - BofA downgraded Figure (FIGR) to Underperform from Neutral with a price target of $42, down from $43, noting a significant valuation gap compared to Coinbase [5] - BNP Paribas downgraded Exxon Mobil (XOM) to Underperform from Neutral with a price target of $125, up from $114, based on valuation concerns [5] - Roth Capital downgraded Coterra Energy (CTRA) to Neutral from Buy with a price target of $28, down from $30, believing no higher offers will materialize at this time [5]

Upgrades - Argus upgraded BHP Group (BHP) to Buy from Hold with a price target of $68, citing firming prices for iron ore, copper, and coal as the global economy improves [2] Downgrades - Jefferies downgraded Mereo BioPharma (MREO) to Hold from Buy with a price target of 50 cents, down from $7, due to Setrusumab missing primary endpoints in trials, impacting Mereo's future strategy [3] - RBC Capital downgraded DigitalBridge (DBRG) to Sector Perform from Outperform with a price target of $16, down from $23, following SoftBank's acquisition announcement at $16 per share, totaling a $4 billion enterprise value [4] Initiations - Stephens initiated coverage of Commvault (CVLT) with an Overweight rating and a $162 price target, highlighting its leadership in data protection and transition to Software-as-a-Service [5] - Stephens initiated coverage of Rubrik (RBRK) with an Overweight rating and a $105 price target, noting its strong growth outlook in data protection and expected margin expansion [5] - Stephens initiated coverage of Varonis (VRNS) with an Equal Weight rating and a $40 price target, emphasizing its growth potential in data security as a Software-as-a-Service platform [5] - Freedom Capital initiated coverage of Ero Copper (ERO) with a Buy rating and a $32 price target, pointing out its high-grade, low-cost assets in Brazil [5] - H.C. Wainwright initiated coverage of Terra Innovatum (NKLR) with a Buy rating and a $25 price target, believing its use of off-the-shelf components will lower regulatory and technological barriers [5]

Core Viewpoint - Top Wall Street analysts have revised their outlook on several prominent stocks, indicating potential investment opportunities in the market [1] Company Analysis - Analysts have provided insights on PRAX stock, suggesting it may be a viable investment option [1]

Upgrades - Jefferies upgraded Onto Innovation (ONTO) to Buy from Hold with a price target of $170, up from $100, citing expected growth reacceleration in the second half of 2026 [2] - Bernstein upgraded United Rentals (URI) to Outperform from Market Perform with a price target of $1,128, up from $885, indicating a 20% upside from current levels, viewing it as a cyclical rebound and portfolio transition story [2] - Guggenheim upgraded Johnson & Johnson (JNJ) to Buy from Neutral with a price target of $206, up from $167, expressing confidence in the company's navigation of Stelara's loss of exclusivity and anticipating growth from its Innovative Medicine business [3] - Wells Fargo upgraded Omnicom (OMC) to Overweight from Equal Weight with a price target of $91, up from $78, highlighting compelling upside potential near the close of the Interpublic Group merger [4] - Wells Fargo also upgraded CoreWeave (CRWV) to Overweight from Equal Weight with a price target of $170, up from $105, noting the company's positioning to benefit from elevated build cycles and hyperscaler industry shortages into 2026 [5] - Melius Research upgraded CoreWeave to Buy from Hold with a price target of $165, up from $128 [5] Downgrades - Baird downgraded Lululemon (LULU) to Neutral from Outperform with a price target of $195, down from $225, due to low near-term confidence in growth and margin trajectory [6] - KeyBanc downgraded Lam Research (LRCX) to Sector Weight from Overweight without a price target, believing strong memory pricing may take time to drive new tool demand [6] - Citizens JMP downgraded CyberArk (CYBR) to Market Perform from Outperform without a price target, citing the pending acquisition by Palo Alto Networks and not anticipating a superior proposal [6] - Seaport Research downgraded Oklo (OKLO) to Neutral from Buy without a price target, acknowledging positives in business development but stepping aside based on valuation [6] - Jefferies downgraded Vistra (VST) to Hold from Buy with a price target of $230, down from $241, following a 160% stock run-up attributed to expectations of a Comanche Peak nuclear deal [6]